1. Repaglinide: a new short-acting insulinotropic agent for the treatment of type 2 diabetes;Owens;Eur J Clin Invest,1999
2. Bioavailability of repaglinide, a novel antidiabetic agent, administered orally in tablet or solution form or intravenously in healthy male volunteers;Hatorp;Int J Clin Pharmacol Ther,1998
3. Single-dose pharmacokinetics of repaglinide in subjects with chronic liver disease;Hatorp;J Clin Pharmacol,2000
4. The effects of selected drugs on the in vitro protein binding of repaglinide in human plasma;Plum;Meth Find Exp Clin Pharmacol,2000
5. Biotransformation of [14C] repaglinide in human, cynomolgus monkey, dog, rabbit, rat and mouse;Bauer;Diabetologia,1997